TEPP inhibitors are a class of chemical compounds designed to inhibit the activity of tetraethyl pyrophosphate (TEPP), a well-known organophosphate compound. TEPP is recognized for its ability to act as an acetylcholinesterase inhibitor, meaning it disrupts the enzyme responsible for breaking down acetylcholine, a neurotransmitter. TEPP inhibitors, in contrast, are compounds developed to selectively bind to and neutralize the activity of TEPP itself, preventing it from interfering with acetylcholinesterase. These inhibitors function by interacting with the reactive sites on the TEPP molecule, rendering it incapable of binding to acetylcholinesterase or other proteins in the same biochemical pathway. The design of TEPP inhibitors often relies on knowledge of TEPP's molecular structure and its specific binding interactions, with a focus on creating molecules that can either competitively or allosterically block TEPP's reactivity.
In research environments, TEPP inhibitors are used to study the effects of organophosphate compounds like TEPP in biological systems, particularly how they interact with enzymes such as acetylcholinesterase. By blocking TEPP's action, researchers can observe the downstream effects and better understand how such compounds influence biochemical and neurological pathways. TEPP inhibitors help delineate the specific molecular mechanisms by which organophosphates act, providing insights into their interactions with proteins and enzymes. Additionally, studies involving TEPP inhibitors often focus on their binding properties, such as affinity and specificity, to explore how effectively these compounds can neutralize TEPP without affecting other biochemical components. This type of research aids in the understanding of the broader role of organophosphate compounds and their modulation within biological systems.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can inhibit a broad range of protein kinases, thereby reducing the phosphorylation activity that is often critical for protein function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, which is involved in the AKT signaling pathway, leading to reduced activity of downstream targets involved in cell survival and metabolism. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK, which acts upstream of ERK in the MAPK pathway, resulting in decreased ERK activation and modulation of gene expression. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
A specific inhibitor of p38 MAPK, thereby inhibiting the response to stress signals and inflammatory cytokines within the cell. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can suppress the mTORC1 complex, affecting protein synthesis and autophagy, processes that are crucial for cell growth and survival. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that can suppress the PI3K-AKT signaling pathway, leading to reduced cell proliferation and increased apoptosis. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase inhibitor that can disrupt the cell cycle by interfering with chromosome alignment and segregation during mitosis. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can prevent the degradation of misfolded proteins, influencing cell cycle regulation and apoptosis. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK1/2, leading to reduced ERK pathway signaling, which is important for cell division and differentiation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, modulating the activity of transcription factors and influencing apoptosis and cell survival. | ||||||